• Company
• ‘Competitors eye Eylea due to its many benefits’
• by Jung, Sae-Im Aug 8, 2023 05:30am

• Policy
• Cough Syrup and Synatura Syrup complete PVA negotiations
• by Lee, Tak-Sun Aug 8, 2023 05:30am

• Company
• Sales of the flu tx market increased due to the endemic
• by Chon, Seung-Hyun Aug 7, 2023 05:23am

• Policy
• Paxlovid and Dong-A’s Diosmin Powder were approved in July
• by Lee, Hye-Kyung Aug 7, 2023 05:23am

• Company
• Prescription of HA eye drops record KRW 166 bil in 1H
• by Kim, Jin-Gu Aug 7, 2023 05:23am

• Policy
• Sotyktu, the world's first TYK2I, received domestic approval
• by Lee, Hye-Kyung Aug 4, 2023 05:38am

• Policy
• Cancer immunotherapy Jemperli passes DREC review
• by Kim, Jung-Ju Aug 4, 2023 05:38am

• Company
• Prescriptions of pseudoephedrine rise 35% in 1H
• by Chon, Seung-Hyun Aug 4, 2023 05:38am

• Company
• Antibiotic resistance is serious
• by Jung, Sae-Im Aug 4, 2023 05:37am

• Policy
• Animal drugs can be manufactured at human drug factories
• by Kang, Shin-Kook Aug 3, 2023 05:35am